Company Insights

CRCA supplier relationships

Explore interactive graphBrowse insights index
CRCA supplier relationship map

CRCA supplier map: who runs, distributes and underwrites the ProShares Ultra CRCL ETF

Thesis: CRCA is an exchange-traded fund product that monetizes through sponsor fee capture, trading spreads and distribution channels—a classic leveraged ETF commercial model executed by an experienced issuer. ProShares sponsors and advises the fund, uses third-party distribution and servicing partners to scale placement, and earns revenue as the active commercial counterparty to market makers and authorized participants. This profile creates concentrated operational dependencies on sponsor and distributor relationships and makes rapid liquidity and distribution execution the dominant commercial levers for investors and counterparties.

Discover more supplier intelligence at https://nullexposure.com/ for sourcing and partner diligence.

Who runs and distributes CRCA — the supply chain in plain English

  • ProShare Advisors LLC is identified in market listings as the entity that issues CRCA shares, which places ProShare Advisors centrally in governance and fund-level decision-making for the ETF. According to TradingView’s listing (FY2025), ProShare Advisors LLC is named as the issuer for CRCA.
  • SEI Investments Distribution Co. functions as the distributor for the fund, providing the intermediary channel to broker-dealers and retail platforms. TradingView’s FY2025 listing specifically identifies SEI Investments Distribution Co. in the distribution role.
  • ProShares (the fund sponsor/operator) launched the ProShares Ultra CRCL ETF (ticker CRCA), a 2x leveraged ETF aimed at doubling the daily performance of Circle Internet Group’s stock; major financial outlets covered the launch in March 2026. A March 2026 Yahoo Finance report and contemporaneous coverage in The Block and CoinCentral described ProShares’ introduction of CRCA as a 2x leveraged vehicle tracking Circle stock.

Each relationship above is directly supported in published market coverage for FY2025–March 2026 and establishes the core supplier triangle for CRCA: sponsor/advisor, distributor, and fund issuer/operator.

What this supplier topology implies for operations and commercial risk

The CRCA supplier map shows a sponsor-centric operating posture with standard external servicing for distribution. That structure produces several working consequences investors should treat as operational facts:

  • Contracting posture: The fund is sponsor-led. ProShare Advisors and ProShares control product design, risk profile and primary fees; service providers (e.g., SEI for distribution) execute go-to-market and settlement roles.
  • Concentration: Commercial exposure is concentrated around the sponsor and the named distributor; those relationships are single points of execution for AUM growth and trade flow.
  • Criticality: Distribution and market-making channels are critical to realized fee revenue—without active placement and tight secondary market liquidity, leveraged ETFs cannot scale fee capture profitably.
  • Maturity: CRCA is a newly launched product (covered in March 2026 press), so operational processes and scale are immature; early performance will be driven by sponsor execution and distributor reach rather than entrenched client flows.

No external constraints (contractual limits, regulatory holds, or vendor restrictions) were returned in the provided company records, which is a company-level signal indicating no explicit third-party contract constraints flagged in public sources for FY2025–March 2026.

Explore how these supplier relationships affect exposure and concentration analysis at https://nullexposure.com/.

Relationship-by-relationship takeaways for investors

  • ProShare Advisors LLC — named issuer. ProShare Advisors is the issuer of CRCA shares and therefore responsible for fund-level governance and the product’s structural design, making it the fulcrum of management decisions and fee policies. (Source: TradingView listing, FY2025.)
  • SEI Investments Distribution Co. — distributor. SEI provides distribution and intermediary services, giving the fund access to brokerage networks and trade-routing platforms required for primary and secondary market placement. (Source: TradingView listing, FY2025.)
  • ProShares — sponsor and fund operator. ProShares launched the Ultra CRCL ETF (CRCA), a 2x leveraged ETF tied to Circle Internet Group stock, and controls sponsor-level commercialization and operational execution. (Sources: Yahoo Finance, The Block, CoinCentral — March 2026 coverage.)

What investors should watch next — active signals and KPIs

Focus on operational metrics that directly reflect supplier effectiveness:

  • AUM growth and net flows: Rapid scale validates distribution execution by SEI and market appetite for leveraged exposure to the underlying equity.
  • Bid-ask spreads and secondary liquidity: Narrow spreads indicate effective market-making and sponsor coordination with authorized participants; wide spreads increase implicit trading costs for holders.
  • Expense structure and fee capture: While ProShares collects sponsor fees, the net economics depend on redemption/creation efficiencies and distribution costs; monitor prospectus for the fund’s stated expense components.
  • Regulatory or product notices: Any changes to leveraged product rules, or specific regulatory guidance on crypto-related equity exposure, will alter the viability of sponsor strategies.

Key risks: sponsor concentration, early-stage liquidity risk, and distribution dependency undercut product economics if market makers and distributors do not scale placement quickly.

How to use this supplier intelligence in diligence

  • Require fund-level filings and sponsor service agreements for vendor-level diligence; validate SEI’s scope and settlement SLAs.
  • Track market commentary and trading statistics in the first 90 days to assess whether distribution and market-making are delivering expected liquidity.
  • Confirm sponsor governance arrangements with ProShare Advisors and review conflict-of-interest disclosures that affect trading and lending activity.

For operational due diligence and ongoing monitoring tools, visit https://nullexposure.com/ to source supplier-level profiles and relationship maps.

Bottom line: concentrated supplier governance, execution is everything

CRCA is a ProShares-sponsored, SEI-distributed leveraged ETF product whose commercial success depends on sponsor execution and distributor scale. The public record for FY2025–March 2026 identifies the three primary relationships without flagging external contractual constraints, producing a clear operational posture: concentrated governance, outsourced distribution, and high sensitivity to initial liquidity and flow dynamics. Investors and operators should prioritize monitoring AUM, spreads and distribution performance as the primary leading indicators of whether the product will deliver durable fee capture.

Act now to incorporate supplier risk into your ETF diligence framework at https://nullexposure.com/.